Promotional events sponsored by the pharmaceutical industry that target health professionals responsible for prescribing medications, such as physicians and nurse practitioners, are a key component of promotional campaigns ...
Jul 5, 2024
0
31
The amount of infectious H5N1 influenza viruses in raw milk rapidly declined with heat treatment in laboratory research conducted by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of ...
Jun 14, 2024
1
35
Various medical circumstances, including heart attacks and extreme cases of COVID-19, necessitate the use of anticoagulants, medicines that prevent blood clots. But the most commonly used, heparin, can induce potentially ...
Aug 21, 2023
0
104
In a remarkable breakthrough, a collaborative team of researchers, led by Professor Yaakov Nahmias from The Hebrew University of Jerusalem, Technion-Israel Institute of Technology, and Tissue Dynamics Ltd., has unveiled a ...
Aug 7, 2023
0
7
Scientists at Simon Fraser University (SFU) and the Lankenau Institute for Medical Research (LIMR) near Philadelphia have found that a drug discovered at SFU and patented several years ago may have potential lifesaving results ...
May 10, 2023
0
69
Professor Sang Yup Lee's research team in KAIST's Department of Biochemical Engineering has developed an advanced AI-based drug interaction prediction technology that analyzed the interaction between Paxlovid ingredients ...
Mar 16, 2023
0
50
In epilepsy research, it has long been assumed that a leaky blood-brain barrier is a cause of inflammation in the brain. Using a novel method, researchers from Bonn University Hospital (UKB) and the University of Bonn have ...
Feb 13, 2023
0
86
For decades, researchers from all over the world have been working hard to understand Alzheimer's disease. Now, a collaboration between the Department of Biomedicine and the Department of Clinical Medicine at Aarhus University ...
Sep 22, 2022
0
50
The repurposing of FDA-approved drugs for alternative diseases is a faster way of bringing new treatments into the clinic. Researchers at Karolinska Institutet in Sweden have repurposed a cancer drug for treatment of neuroinflammatory ...
Jun 6, 2022
0
109
Imatinib, better known as Gleevec, was hailed as a "miracle" cancer drug when it entered the market in the early 2000s. Though it has been highly successful at treating early-stage chronic myeloid leukemia (CML)—a rare ...
Jun 1, 2022
0
150
